BRCA mutations tied to improved survival in ovarian cancer patients
NEW YORK (Reuters Health) – Among women with invasive ovarian cancer, the presence of BRCA germline mutations
NEW YORK (Reuters Health) – Among women with invasive ovarian cancer, the presence of BRCA germline mutations
NEW YORK (Reuters Health) – Mifepristone, a pregnancy-terminating agent, can inhibit ovulation and induce amenorrhea and could,
By Anthony J. Brown, MD NEW YORK (Reuters Health) – The risk of developing breast cancer, particularly
NEW YORK (Reuters Health) – In a randomized, dose-response trial, a 20-cm-squared transdermal contraceptive patch (Ortho Evra)
NEW YORK (Reuters Health) – Most male infertility resulting from a low serum testosterone-to-estradiol ratio can be
By Richard Woodman LONDON (Reuters Health) – Britain's National Institute for Clinical Excellence (NICE) has recommended Schering-Plough's
NEW YORK (Reuters Health) – In couples with unexplained infertility, tubal flushing with lipiodol, an oil-soluble medium,
NEW YORK (Reuters Health) – Analysis of serum proteomic patterns can accurately identify women with ovarian cancer,
By Martha Kerr SAN ANTONIO (Reuters Health) – Efforts to further reduce adverse risks associated oral contraceptive
By Karla Gale NEW YORK (Reuters Health) – For older postmenopausal women, hormone replacement therapy (HRT) appears
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות